Haixia Gao is currently the director of Nucleic Acid Center at Shanghai Cell Therapy Group, a company focuses on the development of cell therapy technology. She joined Shanghai Eastern Hepatobiliary Surgery Hospital as an assistant researcher in 2010, and joined Shanghai Cell Therapy Group CO., LTD in 2017. With years of experience in basic research of cancer immunology, she is dedicated to develop innovative CAR T therapy for treatment of cancer. Her current research focuses on tumor immunotherapy with non-viral vector and mRNA-based therapeutics.